Literature DB >> 21432623

Glucose regulates RMI1 expression through the E2F pathways in adipose cells.

Akira Suwa1, Masayasu Yoshino, Takeshi Kurama, Teruhiko Shimokawa, Ichiro Aramori.   

Abstract

RecQ-mediated genome instability 1 (RMI1) has been identified as a novel energy homeostasis-related molecule. While recent studies have suggested that change in RMI1 expression levels in adipose tissue may affect the body's energy balance, no reports have identified the mechanism behind this expression regulation. In the present study, we found that RMI1 expression increased on differentiation of 3T3-L1 fibroblasts to adipocytes. In addition, glucose stimulation induced RMI1 expression to approximately eight times the baseline level. Further, knockdown of either E2F5 or E2F8 mRNA using siRNA suppressed this glucose-induced up-regulation of RMI1 expression. These results suggest that RMI1 expression may be regulated by glucose, at least in part, via E2F expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21432623     DOI: 10.1007/s12020-011-9455-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

Review 1.  The transcription factor E2F: a crucial switch in the control of homeostasis and tumorigenesis.

Authors:  Z H Fang; Z C Han
Journal:  Histol Histopathol       Date:  2006-04       Impact factor: 2.303

2.  Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage.

Authors:  S Baulande; F Lasnier; M Lucas; J Pairault
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

Review 3.  E2F - at the crossroads of life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Trends Cell Biol       Date:  2008-09-18       Impact factor: 20.808

4.  Adiponutrin gene is regulated by insulin and glucose in human adipose tissue.

Authors:  Marthe Moldes; Geneviève Beauregard; May Faraj; Noël Peretti; Pierre-Henri Ducluzeau; Martine Laville; Rémi Rabasa-Lhoret; Hubert Vidal; Karine Clément
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

5.  RMI1/NCE4, a suppressor of genome instability, encodes a member of the RecQ helicase/Topo III complex.

Authors:  Michael Chang; Mohammed Bellaoui; Chaoying Zhang; Ridhdhi Desai; Pavel Morozov; Lissette Delgado-Cruzata; Rodney Rothstein; Greg A Freyer; Charles Boone; Grant W Brown
Journal:  EMBO J       Date:  2005-05-12       Impact factor: 11.598

6.  Regulation of the PDK4 isozyme by the Rb-E2F1 complex.

Authors:  Michael C F Hsieh; Debopriya Das; Nandakumar Sambandam; Michael Q Zhang; Zaher Nahlé
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

7.  RMI1 deficiency in mice protects from diet and genetic-induced obesity.

Authors:  Akira Suwa; Masayasu Yoshino; Chihiro Yamazaki; Masanori Naitou; Rie Fujikawa; Shun-Ichiro Matsumoto; Takeshi Kurama; Teruhiko Shimokawa; Ichiro Aramori
Journal:  FEBS J       Date:  2009-12-29       Impact factor: 5.542

8.  Role of Fgf10 in cell proliferation in white adipose tissue.

Authors:  Morichika Konishi; Toshiyuki Asaki; Naomi Koike; Hiroyuki Miwa; Ayumi Miyake; Nobuyuki Itoh
Journal:  Mol Cell Endocrinol       Date:  2006-03-02       Impact factor: 4.102

9.  E2Fs regulate adipocyte differentiation.

Authors:  Lluis Fajas; Rebecca L Landsberg; Yolande Huss-Garcia; Claude Sardet; Jacqueline A Lees; Johan Auwerx
Journal:  Dev Cell       Date:  2002-07       Impact factor: 12.270

10.  Functional role of BLAP75 in BLM-topoisomerase IIIalpha-dependent holliday junction processing.

Authors:  Steven Raynard; Weixing Zhao; Wendy Bussen; Lucy Lu; Yang-Yang Ding; Valeria Busygina; Amom Ruhikanta Meetei; Patrick Sung
Journal:  J Biol Chem       Date:  2008-04-04       Impact factor: 5.157

View more
  2 in total

1.  Development of an OP9 derived cell line as a robust model to rapidly study adipocyte differentiation.

Authors:  Jacqueline M Lane; Jamie R Doyle; Jean-Philippe Fortin; Alan S Kopin; José M Ordovás
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

Review 2.  E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma.

Authors:  Yi Lv; Jia Xiao; Jing Liu; Feiyue Xing
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.